Skip to main content
SpringerLink
Log in

Medical costs of AD decrease with time but societal costs increase

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sopina E, et al. Long-term medical costs of Alzheimer's disease: matched cohort analysis European Journal of Health Economics : 31 Aug 2018. Available from: URL: https://doi.org/10.1007/s10198-018-1004-0.

  2. Haro JM, et al. Determinants of time to institutionalisation and related healthcare and societal costs in a community-based cohort of patients with Alzheimer's disease dementia European Journal of Health Economics : 3 Sep 2018. Available from: URL: https://link.springer.com/article/10.1007/s10198-018-1001-3.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Medical costs of AD decrease with time but societal costs increase. PharmacoEcon Outcomes News 812, 22 (2018). https://doi.org/10.1007/s40274-018-5289-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-5289-0

Search

Navigation